RAPT Therapeutics (RAPT) Short Interest Ratio & Short Volume → Urgent new message from Porter Stansberry (From Porter & Company) (Ad) Free RAPT Stock Alerts $8.33 -0.14 (-1.65%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability RAPT Therapeutics Short Interest DataCurrent Short Volume2,490,000 sharesPrevious Short Volume3,510,000 sharesChange Vs. Previous Month-29.06%Dollar Volume Sold Short$21.34 millionShort Interest Ratio / Days to Cover2.2Last Record DateFebruary 29, 2024Outstanding Shares34,800,000 sharesPercentage of Shares Shorted7.16%Today's Trading Volume795,749 sharesAverage Trading Volume2,819,668 sharesToday's Volume Vs. Average28% Short Selling RAPT Therapeutics ? Sign up to receive the latest short interest report for RAPT Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRAPT Short Interest Over TimeRAPT Days to Cover Over TimeRAPT Percentage of Float Shorted Over Time Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. RAPT Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20242,490,000 shares $21.34 million -29.1%N/A2.2 $8.57 2/15/20243,510,000 shares $89.65 million -11.1%N/A3.7 $25.54 1/31/20243,950,000 shares $97.76 million No ChangeN/A9.2 $24.75 1/15/20243,950,000 shares $95.12 million -4.1%N/A9.2 $24.08 12/31/20234,120,000 shares $102.38 million -13.5%N/A9.6 $24.85 12/15/20234,760,000 shares $93.77 million -0.6%N/A11.2 $19.70 Get the Latest News and Ratings for RAPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20234,790,000 shares $69.55 million +12.4%N/A12.4 $14.52 11/15/20234,260,000 shares $51.21 million +6.8%N/A11.7 $12.02 10/31/20233,990,000 shares $52.47 million -6.6%N/A11 $13.15 10/15/20234,270,000 shares $52.26 million -0.9%N/A13.3 $12.24 9/30/20234,310,000 shares $71.63 million +5.1%N/A15.3 $16.62 9/15/20234,100,000 shares $79.95 million +1.2%N/A15 $19.50 8/31/20234,050,000 shares $77.36 million +2.0%N/A13.9 $19.10 8/15/20233,970,000 shares $85.08 million +1.0%N/A13.7 $21.43 7/31/20233,930,000 shares $93.93 million +0.8%N/A14.1 $23.90 7/15/20233,900,000 shares $80.77 million +1.3%N/A13.3 $20.71 6/30/20233,850,000 shares $72.00 million +10.3%N/A11.9 $18.70 6/15/20233,490,000 shares $75.42 million +12.2%N/A9.7 $21.61 5/31/20233,110,000 shares $62.29 million +6.5%N/A7.5 $20.03 5/15/20232,920,000 shares $62.31 million +2.1%N/A6.5 $21.34 4/30/20232,860,000 shares $52.05 million +3.3%N/A6.1 $18.20 4/15/20232,770,000 shares $46.45 million +1.8%N/A5.7 $16.77 3/31/20232,720,000 shares $49.91 million +3.8%N/A5.5 $18.35 3/15/20232,620,000 shares $49.91 million -14.1%N/A5.6 $19.05 2/28/20233,050,000 shares $89.82 million -10.6%N/A7 $29.45 2/15/20233,410,000 shares $97.66 million +6.6%N/A8.2 $28.64 1/31/20233,200,000 shares $92.96 million +2.9%N/A7.5 $29.05 1/15/20233,110,000 shares $81.79 million +2.3%N/A7.8 $26.30 12/30/20223,040,000 shares $60.19 million +17.4%N/A8.4 $19.80 12/15/20222,590,000 shares $46.34 million +3.2%N/A7.4 $17.89 11/30/20222,510,000 shares $44.38 million -9.4%N/A7.1 $17.68 11/15/20222,770,000 shares $65.29 million -9.5%N/A8.3 $23.57 10/31/20223,060,000 shares $66.77 million +6.3%13.3%9.7 $21.82 10/15/20222,880,000 shares $60.16 million +1.1%12.9%9.2 $20.89 9/30/20222,850,000 shares $68.57 million +7.6%12.8%9.4 $24.06 9/15/20222,650,000 shares $70.30 million -3.3%11.9%8.5 $26.53 8/31/20222,740,000 shares $73.19 million +8.7%12.3%8.6 $26.71 8/15/20222,520,000 shares $73.58 million +2.4%11.3%7.8 $29.20 7/31/20222,460,000 shares $45.31 million -3.5%10.8%6.7 $18.42 7/15/20222,550,000 shares $53.27 million -1.5%11.2%6.8 $20.89Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now RAPT Short Interest - Frequently Asked Questions What is RAPT Therapeutics' current short interest? Short interest is the volume of RAPT Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 2,490,000 shares of RAPT short. Learn More on RAPT Therapeutics' current short interest. What is a good short interest ratio for RAPT Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RAPT shares currently have a short interest ratio of 2.0. Learn More on RAPT Therapeutics's short interest ratio. Which institutional investors are shorting RAPT Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of RAPT Therapeutics: Citadel Advisors LLC, ADAR1 Capital Management LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is RAPT Therapeutics' short interest increasing or decreasing? RAPT Therapeutics saw a drop in short interest in the month of February. As of February 29th, there was short interest totaling 2,490,000 shares, a drop of 29.1% from the previous total of 3,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does RAPT Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to RAPT Therapeutics: Foghorn Therapeutics Inc. (6.81%), Verastem, Inc. (3.73%), Werewolf Therapeutics, Inc. (1.73%), Akebia Therapeutics, Inc. (4.08%), Incannex Healthcare Inc. (0.85%), Rigel Pharmaceuticals, Inc. (2.13%), XOMA Co. (2.51%), AC Immune SA (1.10%), Stoke Therapeutics, Inc. (13.52%), Puma Biotechnology, Inc. (11.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short RAPT Therapeutics stock? Short selling RAPT is an investing strategy that aims to generate trading profit from RAPT Therapeutics as its price is falling. RAPT shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RAPT Therapeutics? A short squeeze for RAPT Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RAPT, which in turn drives the price of the stock up even further. How often is RAPT Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RAPT, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Foghorn Therapeutics Short Squeeze Verastem Short Squeeze Werewolf Therapeutics Short Squeeze Akebia Therapeutics Short Squeeze Incannex Healthcare Short Squeeze Rigel Pharmaceuticals Short Squeeze XOMA Short Squeeze AC Immune Short Squeeze Stoke Therapeutics Short Squeeze Puma Biotechnology Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RAPT) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company